Palvella Therapeutics (PVLA) Total Non-Current Liabilities (2013 - 2026)
Palvella Therapeutics (PVLA) recorded Total Non-Current Liabilities of $22.1 million in Q2 2026, up 52.4% from $14.5 million a year earlier and up 11.6% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Palvella Therapeutics reported Total Non-Current Liabilities of $17.8 million, up 49.6% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -24.8% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $11.9 million in FY2024 (-85.3%), $81.02 million in FY2023 (-57.2%), $189.27 million in FY2022 (+84.1%) and $102.81 million in FY2021 (+39.0%).
- The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Total Non-Current Liabilities rose in two of the last four quarters, with growth averaging 1.5%.
- Per Business Quant, the preceding three quarters came in at $19.8 million (Q1 2026), $17.8 million (Q4 2025) and $16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Palvella Therapeutics | 1.77 Bn | 1.52 Bn | - | 22.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.10 Mn |
| Mar 31, 2026 | 19.80 Mn |
| Dec 31, 2025 | 17.80 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 14.50 Mn |
| Mar 31, 2025 | 22.14 Mn |
| Dec 31, 2024 | 11.90 Mn |
| Dec 31, 2023 | 81.02 Mn |
| Jun 30, 2023 | 47.05 Mn |
| Dec 31, 2022 | 189.27 Mn |
| Dec 31, 2021 | 102.81 Mn |
| Sep 30, 2021 | 110.33 Mn |
| Jun 30, 2021 | 108.31 Mn |
| Mar 31, 2021 | 77.55 Mn |
| Dec 31, 2020 | 73.98 Mn |
| Dec 31, 2019 | 89.75 Mn |
| Sep 30, 2019 | 84.03 Mn |
| Jun 30, 2019 | 99.04 Mn |
| Mar 31, 2019 | 100.86 Mn |
| Dec 31, 2018 | 101.38 Mn |
API Access
Palvella Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();